Zomato Cloud Kitchen's 'GLP-1 Friendly' Label Sparks Diet Culture Debate

A cloud kitchen listed on Zomato as Eatfit Lab has ignited an online debate after advertising its food as 'GLP-1 friendly and high protein'. The label, which references a class of prescription weight-loss drugs, has raised questions about the line between medical accommodation and diet culture.

The discussion gained traction after influencer Shreeum Rakheja shared a video questioning the use of a drug's name to market food. She clarified she was not disputing the medical benefits of GLP-1 medications for those who need them, but expressed concern about the growing association of these drugs with appearance and weight loss.

"I was looking for a sandwich on Zomato, and I came across this. GLP-1 friendly and high protein food. A medicine's name is in the title of a restaurant, and we are OK with this," she said, adding that such branding could affect young girls growing up in a culture obsessed with thinness.

A look at Eatfit Lab's menu shows items like a 'Women Wellness Estro Green High Protein Powerhouse Pizza' and a 'Brain Fuel Antioxidant Leafy Green Salad'. These dishes, while nutrient-dense, are not fundamentally different from what one might find at any health-focused eatery.

So, do people on GLP-1 drugs need specially labelled food? Not necessarily, but there is a rationale. GLP-1 receptor agonists, such as semaglutide, reduce appetite and slow digestion, leading to smaller meals. This makes protein, fibre, and nutrient density more important to avoid deficiencies. The Obesity Medicine Association and Cleveland Clinic both recommend prioritising protein and smaller meals for those on these medications.

However, medical guidance does not prescribe a special 'GLP-1 diet'. Foods like eggs, legumes, and leafy greens are simply part of a balanced diet. The label 'GLP-1 friendly' is not a medical certification, and putting it on a menu does not inherently make a dish healthier.

Online reactions have been mixed. Some see the label as practical, helping those on medication identify suitable options. Others criticise it as marketing that exploits a prescription drug's name and potentially fuels unhealthy body image pressures.

Ultimately, the debate reflects a broader cultural shift: weight-loss medication, once confined to doctors' offices, is now appearing on food-delivery apps, bringing with it questions about nutrition, marketing, and body image.